WHO backs Pfizer's oral COVID-19 therapy for high-risk patients

Indonesia Berita Berita

WHO backs Pfizer's oral COVID-19 therapy for high-risk patients
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 gmanews
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 68%

The World Health Organization (WHO) endorsed the use of Pfizer's oral COVID-19 antiviral treatment in high-risk patients after an analysis of trial data by the UN agency showed the therapy dramatically cut the risk of hospitalization.

The recommendation comes as thousands of people die of COVID-19 every week, despite a waning global infection rate. Of existing COVID-19 treatments, Pfizer's Paxlovid is by far the most potent, the WHO said. FILE PHOTO

Other therapies include Merck & Co's MRK.N rival pill molnupiravir, Gilead Sciences' GILD.O intravenous remdesivir and antibody treatments. "These therapeutics do not replace vaccination. They just give us another treatment option for those patients that do get infected that are at higher risk," said Janet Diaz, WHO lead on clinical management, referring to patients with underlying chronic conditions, the immunocompromised or unvaccinated.

These factors have caused Paxlovid supply to eclipse demand in countries where it has been available for some time. Read full story

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

gmanews /  🏆 11. in PH

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

New study finds about 30 percent of COVID-19 patients develop 'Long COVID'New study finds about 30 percent of COVID-19 patients develop 'Long COVID'About 30 percent of people treated for COVID-19 developed Post Acute Sequelae of COVID-19 (PASC), most commonly known as “Long COVID”, according to a new study of the University of California, Los Angeles (UCLA).
Baca lebih lajut »

Covid-19 pneumonia increases dementia risk: studyCovid-19 pneumonia increases dementia risk: studyPatients hospitalized with COVID-19 pneumonia have a higher risk of developing dementia than those with other types of pneumonia, according to a new study from the University of Missouri.
Baca lebih lajut »

QC holds thanksgiving dinner for volunteer doctors of ‘BantAI COVID program’QC holds thanksgiving dinner for volunteer doctors of ‘BantAI COVID program’The Quezon City government held on Monday, April 18, a thanksgiving dinner for volunteer doctors who helped monitor Covid-19 patients through the BantAI COVID program.
Baca lebih lajut »

Vaccination, masking needed to prevent another Covid-19 surgeVaccination, masking needed to prevent another Covid-19 surgeVaccination, masking needed to prevent another Covid-19 surge READ:
Baca lebih lajut »

COVID-19 vaccine doses brought to far-flung areas in Mindanao via dronesCOVID-19 vaccine doses brought to far-flung areas in Mindanao via dronesThe drones reached Tawi-Tawi and Agusan del Sur just eight minutes after takeoff.
Baca lebih lajut »

Shanghai cautiously eases lockdown as deaths riseShanghai cautiously eases lockdown as deaths riseShanghai further eased its grueling, weeks-long COVID-19 lockdown on Wednesday despite a mounting official death toll and tens of thousands of daily cases.
Baca lebih lajut »



Render Time: 2025-03-11 19:57:27